"Mr. Thomas, who has over 22 years of experience in the healthcare industry in various executive positions, was formerly the CEO at Appian Partners, a healthcare advisory firm focused on strategy development and implementation for medical device and healthcare services firms ranging in size from early stage start up to Fortune 50 global conglomerates."
"During his tenure at NST, the company made 12 acquisitions, representing over 80 sleep labs, which resulted in NST becoming the largest U.S. sleep-testing company at that time"
......SOUNDS like our new CEO already built the sales channel for us!
Hope Mr Thomas can lead KSX into Fortune 500/5000 global conglomerates."
KSX Price at posting:
1.4¢ Sentiment: Buy Disclosure: Held